To unravel the mechanism as to how obesity impairs the outcome of DTIC therapy in melanoma, we investigated the specific role of leptin and resistin as their levels in serum are elevated under obese condition. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.